NOMAD POWER SOLUTIONS, INC. Compensation Expense, Excluding Cost of Good and Service Sold
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Compensation Expense, Excluding Cost of Good and Service Sold of $753.53 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold · last filed 2022-08-10
- NOMAD POWER SOLUTIONS, INC. compensation expense, excluding cost of good and service sold for the quarter ending 2022-06-30 was $753.53K, a 28.99% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. compensation expense, excluding cost of good and service sold for the quarter ending 2021-06-30 was $1.06M.
| Period end | Compensation Expense, Excluding Cost of Good and Service Sold 3 month | Compensation Expense, Excluding Cost of Good and Service Sold 6 month |
|---|---|---|
| 2022-06-30 | $753.53K 10-Q · filed 2022-08-10 | $1.32M 10-Q · filed 2022-08-10 |
| 2021-06-30 | $1.06M 10-Q · filed 2022-08-10 | $1.88M 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |